Indaptus Therapeutics, Inc.
corporate_fare Company Profile
Indaptus Therapeutics, Inc. (NASDAQ:INDP) is a publicly traded company in the Healthcare sector. Wiseek monitors INDP SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Indaptus Therapeutics Reports Critical Cash Shortage, Massive Dilution, and Halted Clinical Programs
- Indaptus Therapeutics Reports Critical Cash Shortage, Less Than One Month of Operating Funds Remaining
- Cash Dwindles to $1.5M for Indaptus Therapeutics, Warns of Financing Uncertainty
- Major Investors Disband Group Formed During Recent Dilutive Financing
- Indaptus Therapeutics Appoints Two Independent Directors, Bolstering Financial and IP Expertise
monitoring Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$20.85M
Diluted EPS
-$21.58
Op. Cash Flow
-$14.82M
Operating Income
-$19.83M
Cash & Equivalents
$8.51M
Debt / Equity
0.00×
Shares Outstanding
2.17M sh
Source: 10-K · filed 2026-03-17 · accession 0001493152-26-010585
supervised_user_circle Insider Transactions
-
2026-03-23 Lazar David E. DirectorOpen-market sale 896.8K sh 2 fills derivative
-
2026-02-26 Jabbour Jerome D DirectorGrant/Award 25K sh derivative
-
2026-02-11 Meckler Jeffrey A Co-Chief Executive Officer Officer · DirectorGrant/Award 16.69K sh 3 fills derivative
-
2026-01-20 Ben-Tzvi Avraham DirectorGrant/Award 25K sh
-
2026-01-07 NATAN DAVID DirectorGrant/Award 25K sh derivative
-
2025-12-23 Ben-Tzvi Avraham DirectorGrant/Award 25K sh derivative
-
2025-12-22 Meckler Jeffrey A Co-Chief Executive Officer Officer · Director · 10% OwnerGrant/Award 216.62K sh $439.73K @ $2.03
-
2025-12-22 Linscott Walt Addison Chief Operating Officer OfficerGrant/Award 54.42K sh $110.47K @ $2.03
-
2025-12-22 Sassi Nir Chief Financial Officer OfficerGrant/Award 26.76K sh $54.32K @ $2.03
-
2025-12-22 Newman Michael James CSO and Director Officer · DirectorGrant/Award 52.2K sh $105.97K @ $2.03
-
2025-07-27 Meckler Jeffrey A Chief Executive Officer Officer · DirectorGrant/Award 6.07K sh $50.38K @ $8.30
-
2025-07-27 Meckler Jeffrey A Chief Executive Officer Officer · DirectorGrant/Award 12.14K sh $100.76K @ $8.30 derivative
-
2025-06-10 Hayes William B DirectorGrant/Award 12.5K sh derivative
-
2025-06-10 Martell Robert DirectorGrant/Award 12.5K sh derivative
-
2025-06-10 MADDALUNA ANTHONY J DirectorGrant/Award 12.5K sh derivative
-
2025-06-10 Pomerantz Roger DirectorGrant/Award 30K sh derivative
-
2025-06-10 Karah Hila DirectorGrant/Award 12.5K sh derivative
-
2025-06-10 Gilbert Mark John DirectorGrant/Award 12.5K sh derivative
-
2026-02-11 Meckler Jeffrey A Co-Chief Executive Officer Officer · DirectorNon-cash transfer 16.69K sh 3 fills derivative
From SEC Form 4 + 5 (insider beneficial-ownership filings) · last 12 months · view all on SEC EDGAR ↑
show_chartPrice Chart
Loading chart...
feed INDP - Latest Insights
INDP
May 15, 2026, 8:15 AM EDT
INDP
May 15, 2026, 8:00 AM EDT
INDP
May 15, 2026, 7:00 AM EDT
INDP
Apr 29, 2026, 4:05 PM EDT
INDP
Apr 22, 2026, 9:59 PM EDT
INDP
Apr 03, 2026, 12:00 PM EDT
INDP
Mar 30, 2026, 9:46 PM EDT
INDP
Mar 24, 2026, 4:30 PM EDT
INDP
Mar 24, 2026, 4:05 PM EDT
INDP
Mar 24, 2026, 4:02 PM EDT
INDP
Mar 17, 2026, 4:30 PM EDT
INDP
Mar 02, 2026, 5:20 PM EST
INDP
Feb 27, 2026, 4:05 PM EST
INDP
Feb 12, 2026, 9:30 AM EST
INDP
Feb 12, 2026, 9:30 AM EST
INDP
Jan 21, 2026, 5:21 PM EST
INDP
Jan 20, 2026, 4:06 PM EST
INDP
Jan 08, 2026, 5:26 PM EST
INDP
Jan 08, 2026, 5:22 PM EST
INDP
Jan 02, 2026, 4:07 PM EST